申请人:Peters Dan
公开号:US20070203117A1
公开(公告)日:2007-08-30
This invention relates to novel azabicyclic aryl derivatives which are found to be cholinergic ligands at the nicotinic acetylcholine receptors. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.
本发明涉及一种新型的氮杂双环芳基衍生物,发现它们是乙酰胆碱受体的胆碱能配体。由于它们的药理特性,本发明中的化合物可能对治疗与中枢神经系统(CNS)和外周神经系统(PNS)的胆碱能系统相关的疾病或障碍、平滑肌收缩相关的疾病或障碍、内分泌疾病或障碍、神经退行性疾病或障碍、炎症相关的疾病或障碍、疼痛以及由于滥用化学物质而引起的戒断症状具有广泛的用途。